Attorneys for the FTX founder have inquired about possibly administering extended-release ADHD medication to their client, citing his difficulties maintaining focus throughout the trial. In a letter dated Oct. 15, attorneys for Sam Bankman-Fried reached out to New York District…
Related Posts
Metallica backs Medallion in $13.7m funding round
The family investment firm of rock band Metallica, along with other investors, participated in a Series A funding…
Brock Pierce and Charles Hoskinson talk where crypto is headed in the future after 2025
Cardano founder Charles Hoskinson predicts crypto will dominate the global financial market in the future, erasing the boundaries…
Mantle (MNT) price hits new ATH on RWA buzz and new partnerships
Mantle’s price hit a new all-time high on Tuesday, driven by partnerships that are bootstrapping liquidity and trading…